LYTIR

Company · ALMR

Alamar Biosciences, Inc.

Nasdaq's symbol directory lists ALMR on Nasdaq as “Alamar Biosciences, Inc. - Class A common stock”.

In the 12 months to Nov 8, 2026: insiders sold on 13 occasions ($44.6M); 4 planned-sale notices; 4 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 26, No. 25, No. 24, No. 23, No. 22

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $44.6M in total.Oct: Insider sales $39.9MNov: Insider sales $4.6MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $44.6M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Qiming Corporate GP VI, Ltd. sold on 13 days latest Nov 3, 2026 sold $44.6M
Every trade (13)
  1. SELLQiming Corporate GP VI, Ltd. sold Nov 3, 2026 111,313 shares 4 legs combined filing $3.3M
  2. SELLQiming Corporate GP VI, Ltd. sold Nov 2, 2026 43,930 shares 8 legs combined filing $1.3M
  3. SELLQiming Corporate GP VI, Ltd. sold Oct 30, 2026 143,706 shares 16 legs combined filing $4.4M
  4. SELLQiming Corporate GP VI, Ltd. sold Oct 28, 2026 100,837 shares 8 legs combined filing $3.3M
  5. SELLQiming Corporate GP VI, Ltd. sold Oct 27, 2026 84,894 shares 12 legs combined filing $2.7M
  6. SELLQiming Corporate GP VI, Ltd. sold Oct 26, 2026 132,524 shares 8 legs combined filing $4.0M
  7. SELLQiming Corporate GP VI, Ltd. sold Oct 23, 2026 147,934 shares 12 legs combined filing $4.5M
  8. SELLQiming Corporate GP VI, Ltd. sold Oct 22, 2026 133,811 shares 12 legs combined filing $3.9M
  9. SELLQiming Corporate GP VI, Ltd. sold Oct 21, 2026 208,815 shares 12 legs combined filing $6.3M
  10. SELLQiming Corporate GP VI, Ltd. sold Oct 20, 2026 142,004 shares 12 legs combined filing $4.0M
  11. SELLQiming Corporate GP VI, Ltd. sold Oct 19, 2026 75,508 shares 4 legs combined filing $2.0M
  12. SELLQiming Corporate GP VI, Ltd. sold Oct 16, 2026 136 shares 4 legs combined filing $4K
  13. SELLQiming Corporate GP VI, Ltd. sold Oct 15, 2026 173,537 shares 8 legs combined filing $4.8M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Qiming Venture Partners VI, L.P. filed Oct 14, 2026 Affiliate 1,558,858 shares planned sale date 10/14/2026 filing $36.7M
  2. Qiming Venture Partners VIII-HC, L.P. filed Oct 14, 2026 Affiliate 435,468 shares planned sale date 10/14/2026 filing $10.2M
  3. Qiming Venture Partners VIII Investments, LLC filed Oct 14, 2026 Affiliate 363,729 shares planned sale date 10/14/2026 filing $8.6M
  4. Qiming Managing Directors Fund VI, L.P. filed Oct 14, 2026 Affiliate 41,945 shares planned sale date 10/14/2026 filing $987K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Yuling Luo filed Aug 13, 2026 Schedule 13G passive filing 6.4%
  2. Qiming Corporate GP VI, Ltd. filed Aug 11, 2026 Schedule 13G passive filing 10.2%
  3. Sands Capital Life Sciences Pulse Fund II, L.P. filed Jul 7, 2026 Schedule 13D/A may seek influence 4,230,926 shares filing 6.1%
  4. SHERPA HEALTHCARE FUND II, L.P. filed Jul 2, 2026 Schedule 13G passive filing 5.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Departure or appointment of directors or officers filing Nov 3, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.